Akebia extends vadadustat supply agreement with STA through 2032

Akebia Therapeutics, Inc.

Amendment #1 to Supply Agreement with STA extended term to January 1, 2032.
Volume-based pricing structure and other provisions related to vadadustat drug product amended.
Original Supply Agreement entered February 10, 2021 for manufacturing of vadadustat.

item 1.01

Akebia Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001517022-24-000067

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.